Tenax Therapeutics, Inc. (TENX)
NCM – Real Time Price. Currency in USD
1.63
+0.01 (0.62%)
Market open: Aug 12, 2026, 11:25 AM EDT
1.62
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
1.63
+0.01 (0.62%)
Market open: Aug 12, 2026, 11:25 AM EDT
1.62
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Cash reserves $118.0M barely cover the upcoming debt maturities $0.0
Total current assets $121.7M exceed Total current liabilities $8.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$14.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 15.07 | 6.05 | 10 | |
| Quick ratio | 15.07 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -113K | -8K | N/A | N/A | N/A |
| Operating Income | -11M | -8M | -19M | -56M | -69M |
| Net Income | -11M | -8M | -18M | -53M | -65M |
| EBITDA | -11M | -8M | -19M | -56M | -69M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -1.06 | 1.0 |
| Next quarter | N/A | 2.84 | 2.5 |
| Current year | N/A | -15.85 | 1.0 |
| Next year | N/A | -8.89 | 1.0 |
| Weighted average score | 1.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -13.27 | 0 | -51.99 | 3.3 |
| Y/Y | 999 | -64.12 | -29.62 | -125.92 | 3.3 |
| 3y average | 999 | -98.95 | 58.32 | -80.56 | 5.5 |
| 5y average | 999 | -92.09 | 46.15 | -53.87 | 5.5 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |